Cargando…

Characterisation of progression of macular oedema in the initial stages of diabetic retinopathy: a 3-year longitudinal study

BACKGROUND/OBJECTIVES: To characterise the prevalence and three-year progression of centre-involving diabetic macular oedema (CI-DMO) in minimal to moderate non-proliferative diabetic retinopathy, using optical coherence tomography (OCT) and measurements of retinal fluid using tissue optical reflect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lobo, Conceição, Santos, Torcato, Marques, Inês P., Madeira, Maria H., Santos, Ana Rita, Figueira, João, Cunha-Vaz, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873671/ https://www.ncbi.nlm.nih.gov/pubmed/35066579 http://dx.doi.org/10.1038/s41433-022-01937-3

Ejemplares similares

Association between Neurodegeneration and Macular Perfusion in the Progression of Diabetic Retinopathy: A 3-Year Longitudinal Study
por: Marques, Inês P., et al.
Publicado: (2022)

Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study
por: Marques, Inês P., et al.
Publicado: (2020)

Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy
por: Marques, Ines P., et al.
Publicado: (2020)

Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study
por: Martinho, António C.-V., et al.
Publicado: (2021)

Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study
por: Santos, Ana Rita, et al.
Publicado: (2021)

Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy
por: Ribeiro, Luísa, et al.
Publicado: (2021)

Retinal Neurodegeneration in Different Risk Phenotypes of Diabetic Retinal Disease
por: Madeira, Maria H., et al.
Publicado: (2021)

Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression
por: Marques, Inês P., et al.
Publicado: (2020)

Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy—3-Year Longitudinal Study
por: Marques, Inês P., et al.
Publicado: (2021)

Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study
por: Marques, Inês P., et al.
Publicado: (2022)

Retinal Capillary Nonperfusion in Preclinical Diabetic Retinopathy
por: Santos, Torcato, et al.
Publicado: (2023)

Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR
por: Santos, Torcato, et al.
Publicado: (2022)

OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti–Vascular Endothelial Growth Factor Therapy
por: Farinha, Cláudia, et al.
Publicado: (2020)

Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
por: Romero-Aroca, Pedro, et al.
Publicado: (2016)

Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema
por: Foos, William F, et al.
Publicado: (2022)

Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
por: Amoaku, Winfried M., et al.
Publicado: (2020)

Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
por: Poku, Edith, et al.
Publicado: (2013)

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study
por: Prünte, Christian, et al.
Publicado: (2016)

Microaneurysm turnover is a predictor of diabetic retinopathy progression
por: Pappuru, Rajeev K R, et al.
Publicado: (2019)

Impact of metabolic control on macular thickness in diabetic macular oedema
por: Peng, Yi-Jie, et al.
Publicado: (2017)

Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes
por: Graue-Hernandez, Enrique O, et al.
Publicado: (2020)

Optical coherence tomography imaging of macular oedema
por: Trichonas, George, et al.
Publicado: (2014)

Remote examination of exudates-impact of macular oedema
por: Punniyamoorthy, Uma, et al.
Publicado: (2018)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

Diabetic Macular Oedema Guidelines: An Australian Perspective
por: Yuen, Yew Sen, et al.
Publicado: (2023)

A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS)
por: Stefanickova, Jana, et al.
Publicado: (2018)

Age-Related Macular Degeneration Staging by Color Fundus Photography vs. Multimodal Imaging—Epidemiological Implications (The Coimbra Eye Study—Report 6)
por: Farinha, Cláudia, et al.
Publicado: (2020)

Pseudophakic Cystoid Macular Oedema (PCME) Prevention in Patients with Non-Proliferative Diabetic Retinopathy (NPDR)—Randomized Controlled Trial
por: Jukić, Anđela, et al.
Publicado: (2022)

Comparison of Different Metrics for the Identification of Vascular Changes in Diabetic Retinopathy Using OCTA
por: Mendes, Luis, et al.
Publicado: (2021)

Perifoveal Microcirculation in Macular Oedema with Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2012)

Transient Cystoid Macular Oedema in Multiple Choroidal Naevi
por: Ziahosseini, Kimia, et al.
Publicado: (2013)

Inflammation and Macular Oedema after Pars Plana Vitrectomy
por: Romano, Vito, et al.
Publicado: (2013)

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
por: Shibeeb, O'Sam, et al.
Publicado: (2014)

Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
por: Ahn, Seong Joon, et al.
Publicado: (2018)

Cystoid macular oedema in Cogans syndrome-a case report
por: Pherwani, Anupama, et al.
Publicado: (2008)

Acetazolamide for Cystoid Macular Oedema in Bietti Crystalline Retinal Dystrophy
por: Broadhead, Geoffrey K, et al.
Publicado: (2014)

Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
por: ROA Vandekerckhove, Kristof
Publicado: (2015)

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
por: Mateos-Olivares, Milagros, et al.
Publicado: (2021)

Chronic Macular Oedema as a Late MIRAgel-Related Complication
por: Chean, Chung Shen, et al.
Publicado: (2021)

A multi-centre prospective evaluation of THEIA™ to detect diabetic retinopathy (DR) and diabetic macular oedema (DMO) in the New Zealand screening program
por: Vaghefi, Ehsan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vmr6dpueferc5o3vdujot2t0ij